Effects of sodium hyaluronate and triamcinolone acetonide on glucosaminoglycan metabolism in equine articular chondrocytes treated with interleukin-1.

The research investigated if high-molecular-weight sodium hyaluronate, alone or in partnership with triamcinolone acetonide, could counteract the negative effects of interleukin-1 on the metabolism of glycosaminoglycan in horse joint cells.

Research Objectives

This study aimed to understand the impact of sodium hyaluronate and triamcinolone acetonide on the metabolism of glycosaminoglycan (GAG) in equine articular chondrocytes negatively affected by interleukin (IL)-1. The researchers wanted to ascertain if these substances could alleviate the harm IL-1 inflicts on chondrocytes and promote healthy GAG metabolism.

Methodology

• The research involved chondrocytes obtained from the metacarpophalangeal joints of 10 horses, which were euthanized for unrelated reasons.
• A variety of treatments were used on the chondrocyte pellets: some received only medium (negative control), others had medium with IL-1 (positive control), and other groups also had the addition of hyaluronic acid (at two different concentrations), triamcinolone acetonide (at two different concentrations), or a combination of either concentration of hyaluronic acid and either concentration of triamcinolone acetonide.
• After these treatments, the chondrocyte pellets were tested for newly formed GAG, total GAG content, total DNA content, and the mRNA for three elements: aggrecan, collagen type II, and cyclooxygenase (COX)-2.

Results

• The application of high-concentration hyaluronic acid boosted GAG synthesis while high-concentration triamcinolone acetonide reduced GAG loss into the medium. Both elements increased total GAG content when used at high concentrations.
• The treatments did not affect the DNA content.
• Triamcinolone acetonide lessened the expression of COX-2 mRNA, aggrecan, and collagen type II. Hyaluronic acid did not have any effect on mRNA for COX-2, aggrecan, or collagen type II.

Conclusions and Clinical Relevance

The research findings highlight the potential of high-concentration hyaluronic acid and triamcinolone acetonide on their own, or together, to counteract the side effects of IL-1 administration on GAG metabolism in equine chondrocytes. The results open up possibilities for further study and potential therapeutic applications to maintain joint health in horses.